Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report

By P. Malfertheiner, F. Mégraud, C. O'Morain, J. Atherton, A. Axon, F. Bazzoli, Gian Franco Gensini, J. Gisbert, D. Graham, T. Rokkas and 2 more. Gut, 2012

2,464 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/58414e7878e5a3bbfc446a576cdb03d054c01f1d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. Jason Y. Park
2. D. Graham
3. M. Valasek
4. Samir Gupta
5. H. Aramin
6. I. Thung
7. S. Crowe
8. V. Vavinskaya

Citations in the corpus

• Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. (2016, background): “22 clarithromycin according to the 15%-20% threshold of macrolide resistance in a specific population.(9) In light of the unequivocal benefit of H pylori eradication, future long-term placebo controlled trials for high-risk population would be unethical.”
• Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. (2014, background): “pylori infection [43] and other risk factors, including tobacco and diet [56], as well as exposures associated with cancer of the cardia, such as reflux disease [57] and obesity [58], which have been increasing in Central and Northern Europe [59] and in North America [8].”
• Review article: the global emergence of Helicobacter pylori antibiotic resistance (2015, background): “pylori antibiotic resistance rates exceed 20% in the population of interest.(1) In addition, a review of patients’ prior antibiotic use is important to increase cure rates as prior exposure to macrolides increase H.”